FORT WAYNE, IN – BioPoly, LLC has entered into an exclusive distribution agreement with Canada-based distributor, Verve Medical Products, Inc., to distribute the BioPoly® partial resurfacing family of products throughout Canada, with distribution initially taking place through the Canadian SAP. Verve Medical Products specializes in bringing medical-surgical products to Canada through its distribution and regulatory services. Herb Schwartz, BioPoly President, said “The introduction of BioPoly’s product portfolio into North America, specifically the Canadian market, is a major accomplishment for our Company. Verve Medical Products is one of Canada’s leading medical device distributors, and we are looking forward to working with their team to provide Canadian orthopaedic surgeons with a proven option for the treatment of articular cartilage defects.”BioPoly implants have been used in knee surgeries throughout Europe since 2012. The fact that BioPoly partial resurfacing implants are designed to replace only the damaged cartilage of a patient’s joint, rather than replacing the entire joint, allows patients to quickly return to active, pain-free lifestyles. The key feature of the Company’s implants is the BioPoly® material, which is a patented combination of ultra-high molecular weight polyethylene and hyaluronic acid. The material is essentially a “self-lubricated” polymer that is extremely biocompatible with cartilage tissues. After it is implanted, the BioPoly® material attracts joint fluid to its surface for lubrication, similar to native cartilage; thus, BioPoly implants are used to replace damaged cartilage (i.e. partially resurface) in joints. The BioPoly family of partial resurfacing products (RS Knee, RS Patella, and RS Trochlea) are CE marked and currently available throughout Europe, parts of Southeast Asia, and now Canada.
About BioPoly, LLC
BioPoly LLC is an ISO 13485 certified orthopaedic implant manufacturer located in Fort Wayne, Indiana. The Company is developing, manufacturing and marketing products for use in sports medicine and orthopaedics. Additional medical applications of the BioPoly® technology in cardiovascular, spinal, and trauma markets are also being pursued. BioPoly knee products are CE marked but have not been FDA cleared. They are part of an FDA approved clinical study; however, they are not yet available in the US.
Additional information about BioPoly LLC and its partial joint resurfacing technology can be found on the BioPoly website.
